Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
- Citation:
- J Clin Oncol vol 25 (18) 2567-72
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- CA-25224, CA-35101, CA-35103, CA-35113, CA-35195, CA-35269, CA-35415, CA-35431, CA-35448, CA-37404, CA-37417, CA-52352, CA-60276, CA-63848
- Corr. Author:
- Authors:
- Michael G Haddock Revathi Swaminathan Nathan R Foster Mark D Hauge James A Martenson John K Camoriano Philip J Stella Richard C Tenglin Paul L Schaefer Dennis F Moore Steven R Alberts
- Networks:
- Study
- NCCTG-N9942
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adenocarcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Combined Modality Therapy, Deoxycytidine, Disease Progression, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Radiotherapy Dosage, Survival Rate, Treatment Outcome